Strategic leukofiltration in cardiac surgery

Area of Science:

• Cardiovascular Surgery
• Immunology
• Biomaterials Science

Background:

• Systemic inflammatory response syndrome (SIRS) is a frequent complication following cardiac surgery, potentially leading to organ dysfunction.
• Leukocyte reduction (leukoreduction) via filtration is a strategy explored to mitigate SIRS, but existing literature presents discrepancies.
• Understanding the precise role of leukofiltration in managing SIRS post-cardiac surgery remains crucial for improving patient outcomes.

Purpose of the Study:

• To review recent literature on leukoreduction and SIRS following cardiac surgery, identifying areas of conflicting findings.
• To evaluate the clinical outcomes and efficacy of leukofiltration in attenuating SIRS.
• To assess indirect indicators of SIRS, platelet function, and biomaterial interactions associated with leukofiltration.

Main Methods:

• Review of recent scientific literature concerning SIRS and leukoreduction in cardiac surgery.
• Analysis of indirect indicators of SIRS.
• Assessment of platelet function using thromboelastography.
• Biomaterial evaluation via light and scanning electron microscopy.

Main Results:

• Discrepancies exist in the current literature regarding the effectiveness of leukoreduction in attenuating SIRS.
• The study presents conclusions on clinical outcomes related to leukofiltration.
• Findings address the role of leukofiltration by examining SIRS indicators, platelet function, and biomaterial properties.

Conclusions:

• Leukofiltration may play a role in ameliorating SIRS following cardiac surgery, though further research is needed to resolve existing literature discrepancies.
• The study provides insights into the clinical impact and mechanisms of leukofiltration.
• Comprehensive evaluation of SIRS indicators, platelet function, and biomaterials is essential for understanding leukofiltration's benefits.